4.6 Letter

Opioid withdrawal management in the fentanyl era

Related references

Note: Only part of the references are listed.
Article Substance Abuse

Clinical Management of Opioid Withdrawal

Kristine E. Torres-Lockhart et al.

Summary: Appropriate clinical management is essential for opioid withdrawal, as it reduces the risks of overdose and relapse. This narrative review provides evidence-based strategies for opioid withdrawal management, including complex cases, relapse prevention, and new developments.

ADDICTION (2022)

Editorial Material Medicine, General & Internal

Treating Opioid Withdrawal in the Hospital: A Role for Short-Acting Opioids

Robert A. Kleinman et al.

ANNALS OF INTERNAL MEDICINE (2022)

Editorial Material Substance Abuse

A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era

Kimberly L. Sue et al.

Summary: With the worst opioid overdose crisis in the history of the United States, there is an urgent need for new methods to assist drug users in initiating medication for opioid use disorder. The conventional ways of buprenorphine initiation must be augmented with additional novel approaches, as reported by addiction medicine clinicians and drug user union representatives.

JOURNAL OF ADDICTION MEDICINE (2022)

Review Substance Abuse

Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach

Shawn M. Cohen et al.

Summary: Low dose buprenorphine initiation is an alternative method that gradually increases the treatment dose, avoiding opioid withdrawal symptoms and allowing simultaneous use of full opioid agonists. However, there is limited evidence and a need for clear usage guidelines.

JOURNAL OF ADDICTION MEDICINE (2022)

Editorial Material Medicine, General & Internal

Short-Acting Opioids for Hospitalized Patients With Opioid Use Disorder

Ashish P. Thakrar

JAMA INTERNAL MEDICINE (2022)

Article Immunology

Against Medical Advice Discharges in Injection and Non-injection Drug Use-associated Infective Endocarditis: A Nationwide Cohort Study

Simeon D. Kimmel et al.

Summary: The study reveals that AMA discharges are more common among patients with Injection drug use-associated infective endocarditis (IDU-IE) and the trend is increasing annually, indicating the need for targeted interventions to reduce such occurrences.

CLINICAL INFECTIOUS DISEASES (2021)

Article Substance Abuse

Hospital Initiated Injectable Opioid Agonist Therapy for the Treatment of Severe Opioid Use Disorder: A Case Series

Rupinder Brar et al.

Summary: This study explored the effectiveness of initiating iOAT in a hospital setting for treatment refractory individuals with severe OUD, showing that all participants stayed until recommended discharge after iOAT initiation, with an average total dose of intravenous hydromorphone used during titration being 100 mg on day 1, and 200 mg on days 2 to 3. All patients continued iOAT treatment post-discharge.

JOURNAL OF ADDICTION MEDICINE (2021)

Article Substance Abuse

The dawn of a new synthetic opioid era: the need for innovative interventions

Bryce Pardo et al.

Summary: The influx of illegally manufactured synthetic opioids into street drugs is increasing the risk of fatal overdoses. In some areas, synthetic opioids like fentanyl have virtually replaced traditional drugs like heroin. The concealment of synthetic opioids in substances sold as heroin or counterfeit medications is causing significant harm and poses unprecedented challenges to drug policy.

ADDICTION (2021)

Article Health Care Sciences & Services

Treating Fentanyl Withdrawal

Geoff Neimark et al.

JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH (2020)

Review Pharmacology & Pharmacy

Metabolic Pathways and Potencies of New Fentanyl Analogs

Maurice Wilde et al.

FRONTIERS IN PHARMACOLOGY (2019)

Editorial Material Substance Abuse

Yes, people can die from opiate withdrawal

Shane Darke et al.

ADDICTION (2017)

Review Chemistry, Medicinal

Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications

Ruben S. Vardanyan et al.

FUTURE MEDICINAL CHEMISTRY (2014)

Article Medicine, General & Internal

Increased Risk of Mortality and Readmission among Patients Discharged Against Medical Advice

William N. Southern et al.

AMERICAN JOURNAL OF MEDICINE (2012)

Review Pharmacology & Pharmacy

Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human

Michael M. Morgan et al.

BRITISH JOURNAL OF PHARMACOLOGY (2011)

Article Psychology, Clinical

The clinical opiate withdrawal scale (COWS)

DR Wesson et al.

JOURNAL OF PSYCHOACTIVE DRUGS (2003)